Ebv LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine

Journal of Leukocyte Biology

Volumn 90, Issue 2, 2011, Pages 389-398

  Gupta, Sachin ^a   Termini, James M ^a   Niu, Liguo ^a,c   Kanagavelu, Saravana K ^a   Schmidtmayerova, Helena ^a   Snarsky, Victoria ^b,d   Kornbluth, Richard S ^a,b   Stone, Geoffrey W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d BIOTHERAPEUTICS INC   (United States)

Author keywords

Antigen presenting cell; Attenuated viral vaccines; Macrophages

Indexed keywords

CD40 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROPORATION; EPSTEIN BARR VIRUS; GENE CASSETTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNIZATION; MACROPHAGE; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRION;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANTIGEN PRESENTATION; ANTIGENS, CD40; DENDRITIC CELLS; HERPESVIRUS 4, HUMAN; HIV; HUMANS; MOLECULAR MIMICRY; TRANSDUCTION, GENETIC; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79961054169     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0211068     Document Type: Article

References (54)

1. Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., Pulendran, B. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424.
2. Delgado, M. F., Coviello, S., Monsalvo, A. C., Melendi, G. A., Hernandez, J. Z., Batalle, J. P., Diaz, L., Trento, A., Chang, H. Y., Mitzner, W., Ravetch, J., Melero, J. A., Irusta, P. M., Polack, F. P. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15, 34-41.
3. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P., Steinman, R. M. (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 101, 7669-7674.
4. Zhang, R., Lifson, J. D., Chougnet, C. (2006) Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood 107, 1989-1995.
5. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F., Heath, W. R. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393, 478-480.
6. Ridge, J. P., Di Rosa, F., Matzinger, P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478.
7. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40- CD40L interactions. Nature 393, 480-483.
8. Callan, M. F., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D., O'Callaghan, C. A., Steven, N., McMichael, A. J., Rickinson, A. B. (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187, 1395-1402.
9. Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., Callan, M. F. (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162, 1827-1835.
10. Graham, J. P., Arcipowski, K. M., Bishop, G. A. (2010) Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol. Rev. 237, 226-248.
11. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., Bilska, M., Kothe, D. L., Salazar-Gonzalez, J. F., Wei, X., Decker, J. M., Hahn, B. H., Montefiori, D. C. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125.
12. Stone, G. W., Barzee, S., Snarsky, V., Kee, K., Spina, C. A., Yu, X. F., Kornbluth, R. S. (2006) Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J. Virol. 80, 1762-1772.
13. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D., Hammerschmidt, W. (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131-6140.
14. Hatzivassiliou, E., Miller, W. E., Raab-Traub, N., Kieff, E., Mosialos, G. (1998) A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-κ B, and stress-activated protein kinase. J. Immunol. 160, 1116-1121.
15. Baxendale, A. J., Dawson, C. W., Stewart, S. E., Mudaliar, V., Reynolds, G., Gordon, J., Murray, P. G., Young, L. S., Eliopoulos, A. G. (2005) Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth. Oncogene 24, 7913-7923.
16. H ömig-Hölzel, C., Hojer, C., Rastelli, J., Casola, S., Strobl, L. J., Muller, W., Quintanilla-Martinez, L., Gewies, A., Ruland, J., Rajewsky, K., Zimber- Strobl, U. (2008) Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis. J. Exp. Med. 205, 1317-1329.
17. Levy, D. N., Aldrovandi, G. M., Kutsch, O., Shaw, G. M. (2004) Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA 101, 4204-4209.
18. Munis, J. R., Kornbluth, R. S., Guatelli, J. C., Richman, D. D. (1992) Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages. J. Gen. Virol. 73, 1899-1906.
19. Streeck, H., Frahm, N., Walker, B. D. (2009) The role of IFN-γ Elispot assay in HIV vaccine research. Nat. Protoc. 4, 461-469.
20. Eliopoulos, A. G., Stack, M., Dawson, C. W., Kaye, K. M., Hodgkin, L., Sihota, S., Rowe, M., Young, L. S. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14, 2899-2916.
21. Boczkowski, D., Nair, S. K., Snyder, D., Gilboa, E. (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465-472.
22. Snijders, A., Kalinski, P., Hilkens, C. M., Kapsenberg, M. L. (1998) Highlevel IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10, 1593-1598.
23. Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A., Reis e Sousa, C. (2000) CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453-462.
24. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
25. Förster, R., Davalos-Misslitz, A. C., Rot, A. (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362-371.
26. Kiener, P. A., Moran-Davis, P., Rankin, B. M., Wahl, A. F., Aruffo, A., Hollenbaugh, D. (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155, 4917-4925.
27. Wilson, C. C., Olson, W. C., Tuting, T., Rinaldo, C. R., Lotze, M. T., Storkus, W. J. (1999) HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines. J. Immunol. 162, 3070-3078.
28. Brooks, J. M., Lee, S. P., Leese, A. M., Thomas, W. A., Rowe, M., Rickinson, A. B. (2009) Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition. J. Immunol. 182, 1919-1928.
29. Henriquez, N. V., Floettmann, E., Salmon, M., Rowe, M., Rickinson, A. B. (1999) Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1. J. Immunol. 162, 3298-3307.
30. Hislop, A. D., Annels, N. E., Gudgeon, N. H., Leese, A. M., Rickinson, A. B. (2002) Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195, 893-905.
31. Ruby, J., Bluethmann, H., Aguet, M., Ramshaw, I. A. (1995) CD40 ligand has potent antiviral activity. Nat. Med. 1, 437-441.
32. Liu, J., Yu, Q., Stone, G. W., Yue, F. Y., Ngai, N., Jones, R. B., Kornbluth, R. S., Ostrowski, M. A. (2008) CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8(+) T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals. Vaccine 26, 4062-4072.
33. Kato, K., Cantwell, M. J., Sharma, S., Kipps, T. J. (1998) Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J. Clin. Invest. 101, 1133-1141.
34. Kikuchi, T., Miyazawa, N., Moore, M. A., Crystal, R. G. (2000) Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Cancer Res. 60, 6391-6395.
35. Zhang, L., Tang, Y., Akbulut, H., Zelterman, D., Linton, P. J., Deisseroth, A. B. (2003) An adenoviral vector cancer vaccine that delivers a tumorassociated antigen/CD40-ligand fusion protein to dendritic cells. Proc. Natl. Acad. Sci. USA 100, 15101-15106.
36. Koya, R. C., Kasahara, N., Favaro, P. M., Lau, R., Ta, H. Q., Weber, J. S., Stripecke, R. (2003) Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery. J. Immunother. 26, 451-460.
37. Lin, F. C., Peng, Y., Jones, L. A., Verardi, P. H., Yilma, T. D. (2009) Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle simian immunodeficiency viruses enhances immunogenicity. J. Virol. 83, 1216-1227.
38. Martin, G., Tremblay, M. J. (2004) HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin. Immunol. 111, 275-285.
39. Skountzou, I., Quan, F. S., Gangadhara, S., Ye, L., Vzorov, A., Selvaraj, P., Jacob, J., Compans, R. W., Kang, S. M. (2007) Incorporation of glycosylphosphatidylinositol- anchored granulocyte-macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles. J. Virol. 81, 1083-1094.
40. Zhang, R., Zhang, S., Li, M., Chen, C., Yao, Q. (2010) Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLPinduced dendritic cell activation and boosts immune responses against HIV. Vaccine 28, 5114-5127.
41. Huang, D., Pereboev, A. V., Korokhov, N., He, R., Larocque, L., Gravel, C., Jaentschke, B., Tocchi, M., Casley, W. L., Lemieux, M., Curiel, D. T., Chen, W., Li, X. (2008) Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells. Gene Ther. 15, 298-308.
42. Epeldegui, M., Thapa, D. R., De la Cruz, J., Kitchen, S., Zack, J. A., Martinez-Maza, O. (2010) CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS ONE 5, e11448.
43. Martin, G., Roy, J., Barat, C., Ouellet, M., Gilbert, C., Tremblay, M. J. (2007) Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. J. Virol. 81, 5872-5881.
44. Maurais, E., Cantin, R., Tremblay, M. J. (2009) Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages. Virology 385, 227-232.
45. Hanks, B. A., Jiang, J., Singh, R. A., Song, W., Barry, M., Huls, M. H., Slawin, K. M., Spencer, D. M. (2005) Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. Nat. Med. 11, 130-137.
46. Marzio, G., Verhoef, K., Vink, M., Berkhout, B. (2001) In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. USA 98, 6342-6347.
47. Das, A. T., Klaver, B., Centlivre, M., Harwig, A., Ooms, M., Page, M., Almond, N., Yuan, F., Piatak Jr., M., Lifson, J. D., Berkhout, B. (2008) Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Retrovirology 5, 44.
48. Evans, D. T., Bricker, J. E., Desrosiers, R. C. (2004) A novel approach for producing lentiviruses that are limited to a single cycle of infection. J. Virol. 78, 11715-11725.
49. Yang, L., Yang, H., Rideout, K., Cho, T., Joo, K. I., Ziegler, L., Elliot, A., Walls, A., Yu, D., Baltimore, D., Wang, P. (2008) Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat. Biotechnol. 26, 326-334.
50. Wingard, J. B., Anderson, B., Weissman, D. (2008) Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine. Eur. J. Immunol. 38, 1310-1320.
51. Ahonen, C. L., Doxsee, C. L., McGurran, S. M., Riter, T. R., Wade, W. F., Barth, R. J., Vasilakos, J. P., Noelle, R. J., Kedl, R. M. (2004) Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med. 199, 775-784.
52. Bonehill, A., Tuyaerts, S., Van Nuffel, A. M., Heirman, C., Bos, T. J., Fostier, K., Neyns, B., Thielemans, K. (2008) Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. Mol. Ther. 16, 1170-1180.
53. Cisco, R. M., Abdel-Wahab, Z., Dannull, J., Nair, S., Tyler, D. S., Gilboa, E., Vieweg, J., Daaka, Y., Pruitt, S. K. (2004) Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive Toll-like receptor 4. J. Immunol. 172, 7162-7168.
54. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., Lanzavecchia, A. (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6, 769-776.